MSD has announced that patients aged 70 years or older with a Bone Mineral Density (BMD) T-score of -2.5 or lower and no prior osteoporotic fracture, are now able to access osteoporosis treatment on the PBS. more

The Australian Therapeutic Goods Administration (TGA) has approved VICTRELIS for the treatment of chronic hepatitis C, genotype 11, the most common form of the condition affecting 55% of all sufferers. more

Today, a Full Court of the Federal Court of Australia delivered its judgment in the appeal of the Peterson case...more

Patients attending selected drug and alcohol clinics will be offered non-invasive liver screening and peer-based counselling as part of a program to help prevent more than 1,000 Australian deaths each year from liver disease... more

MSD, a global pharmaceutical company, announced Barnardos has been selected as its local charity of choice, providing an annual corporate sponsorship of $100,000 and pledging significant volunteering resources through its broad and diverse employee base to the charity...more

New research released today exposes the full force of migraine on Australian society and the severe impact it can have on the one in five Australian households ... more